| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acquired hemophilia following COVID‐19 vaccination: Case report and review of literature
|
Happaerts, Michiel
|
|
|
6 |
6 |
p.
|
artikel
|
| 2 |
Alteplase or tenecteplase for thrombolysis in ischemic stroke: An illustrated review
|
Zhu, Annie
|
|
|
6 |
6 |
p.
|
artikel
|
| 3 |
Anticoagulation stewardship: Descriptive analysis of a novel approach to appropriate anticoagulant prescription
|
Koolian, Maral
|
|
|
6 |
6 |
p.
|
artikel
|
| 4 |
A systematic review of biomarkers among hospitalized patients with COVID‐19 predictive of venous thromboembolism: A communication from the Predictive and Diagnostic Variables Scientific and Standardization Committee of the ISTH
|
Woller, Scott C.
|
|
|
6 |
6 |
p.
|
artikel
|
| 5 |
Authorship diversity in hematology‐related Cochrane systematic reviews: Inequities in global representation
|
Biswas, Jyotirmoy
|
|
|
6 |
6 |
p.
|
artikel
|
| 6 |
Bleeding in women with venous thromboembolism during pregnancy: A systematic review of the literature
|
Simard, Camille
|
|
|
6 |
6 |
p.
|
artikel
|
| 7 |
Challenges and knowledge gaps facing hemophilia carriers today: Perspectives from patients and health care providers
|
Chaigneau, Megan
|
|
|
6 |
6 |
p.
|
artikel
|
| 8 |
Characteristics and predictors of venous thrombosis recurrence in patients with cancer and catheter‐related thrombosis
|
Lipe, Demis N.
|
|
|
6 |
6 |
p.
|
artikel
|
| 9 |
Desmopressin for bleeding in non‐severe hemophilia A: Suboptimal use in a real‐world setting
|
Zwagemaker, Anne‐Fleur
|
|
|
6 |
6 |
p.
|
artikel
|
| 10 |
Desmopressin testing in von Willebrand disease: Lowering the burden
|
Heijdra, Jessica M.
|
|
|
6 |
6 |
p.
|
artikel
|
| 11 |
Epidemiology, treatment patterns, clinical outcomes, and disease burden among patients with immune‐mediated thrombotic thrombocytopenic purpura in the United States
|
Adeyemi, Ayoade
|
|
|
6 |
6 |
p.
|
artikel
|
| 12 |
Estimating incidence of venous thromboembolism in COVID‐19: Methodological considerations
|
Nab, Linda
|
|
|
6 |
6 |
p.
|
artikel
|
| 13 |
Hormonal therapies and venous thrombosis: Considerations for prevention and management
|
LaVasseur, Corinne
|
|
|
6 |
6 |
p.
|
artikel
|
| 14 |
Impact factor to discovery: The future of thrombosis and hemostasis research
|
Cushman, Mary
|
|
|
6 |
6 |
p.
|
artikel
|
| 15 |
Implementing evidence‐based anticoagulant prescribing: User‐centered design findings and recommendations
|
Seagull, F. Jacob
|
|
|
6 |
6 |
p.
|
artikel
|
| 16 |
Issue Information
|
|
|
|
6 |
6 |
p.
|
artikel
|
| 17 |
Lupus anticoagulant associates with thrombosis in patients with COVID‐19 admitted to intensive care units: A retrospective cohort study
|
Noordermeer, Tessa
|
|
|
6 |
6 |
p.
|
artikel
|
| 18 |
New and known predictors of the postthrombotic syndrome: A subanalysis of the ATTRACT trial
|
Rinfret, Félix
|
|
|
6 |
6 |
p.
|
artikel
|
| 19 |
Risk factors for inhibitors in hemophilia A based on RNA‐seq and DNA methylation
|
Liu, Wei
|
|
|
6 |
6 |
p.
|
artikel
|
| 20 |
Rotational thromboelastometry in critically ill COVID‐19 patients does not predict thrombosis
|
Dujardin, Romein W.G.
|
|
|
6 |
6 |
p.
|
artikel
|
| 21 |
Socioeconomic participation of persons with hemophilia: Results from the sixth hemophilia in the Netherlands study
|
van Balen, Erna C.
|
|
|
6 |
6 |
p.
|
artikel
|
| 22 |
Standardization of D‐dimer reporting in the COVID‐19 era
|
Zhang, Litao
|
|
|
6 |
6 |
p.
|
artikel
|
| 23 |
Thromboelastography and thrombin generation assessments for pediatric severe hemophilia A patients are highly variable and not predictive of clinical phenotypes
|
Mathews, Natalie
|
|
|
6 |
6 |
p.
|
artikel
|
| 24 |
Treatment of immune thrombocytopenia in Australian adults: A multicenter retrospective observational study
|
Rosenberg, Adam
|
|
|
6 |
6 |
p.
|
artikel
|
| 25 |
Untreated bleeds in people with hemophilia A in a noninterventional study and intrapatient comparison after initiating emicizumab in HAVEN 1–3
|
Callaghan, Michael U.
|
|
|
6 |
6 |
p.
|
artikel
|
Tijdschrift beschrijving